Background Since the start of the novel coronavirus 2019 (COVID-19) pandemic,
corticosteroid use has been the subject of debate. The available evidence is uncertain, and …

Background The impact of corticosteroid therapy on outcomes of patients with coronavirus
disease 2019 (COVID-19) is highly controversial. We aimed to compare the risk of death …

Systemic corticosteroids have emerged as a possible therapy to mitigate lung injury in
severe COVID-19 infection. Here, we provide historical context for corticosteroid …

Background Low-dose corticosteroids have been shown to reduce mortality for hypoxic
COVID-19 patients requiring oxygen or ventilatory support (non-invasive mechanical …

Inhaled corticosteroids (ICSs) are the mainstay of anti-inflammatory therapy for asthma and
chronic obstructive pulmonary disease (COPD). 1, 2 Studies have shown worse outcomes in …

Objective There are no controlled studies on the role of systemic corticosteroids (CS) in
patients with coronavirus disease 2019 (COVID-19). In the absence of high-quality …

The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-
19. A systematic search of the literature across nine databases was conducted from …

Background It is unclear the efficacy and safety of glucocorticoids compared with placebo or
usual care for treatment of COVID-19. Research design and methods Randomized …

Background: Systemic corticosteroids are associated with reduced mortality in COVID-19-
related acute respiratory failure; however, the type and dose has not yet been established …

Background: The comorbidities and clinical signs of coronavirus disease 2019 (COVID-19)
patients have been reported mainly as descriptive statistics, rather than quantitative analysis …